Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer.

Gimple RC, Bhargava S, Dixit D, Rich JN.

Genes Dev. 2019 Jun 1;33(11-12):591-609. doi: 10.1101/gad.324301.119. Review.

PMID:
31160393
2.

Reciprocal Signaling between Glioblastoma Stem Cells and Differentiated Tumor Cells Promotes Malignant Progression.

Wang X, Prager BC, Wu Q, Kim LJY, Gimple RC, Shi Y, Yang K, Morton AR, Zhou W, Zhu Z, Obara EAA, Miller TE, Song A, Lai S, Hubert CG, Jin X, Huang Z, Fang X, Dixit D, Tao W, Zhai K, Chen C, Dong Z, Zhang G, Dombrowski SM, Hamerlik P, Mack SC, Bao S, Rich JN.

Cell Stem Cell. 2018 Apr 5;22(4):514-528.e5. doi: 10.1016/j.stem.2018.03.011.

3.

Potential therapeutic implications of cancer stem cells in glioblastoma.

Cheng L, Bao S, Rich JN.

Biochem Pharmacol. 2010 Sep 1;80(5):654-65. doi: 10.1016/j.bcp.2010.04.035. Epub 2010 May 10. Review.

4.

Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs.

Safa AR, Saadatzadeh MR, Cohen-Gadol AA, Pollok KE, Bijangi-Vishehsaraei K.

Genes Dis. 2015 Jun;2(2):152-163.

5.

Chromatin remodeler HELLS maintains glioma stem cells through E2F3 and MYC.

Zhang G, Dong Z, Prager BC, Kim LJ, Wu Q, Gimple RC, Wang X, Bao S, Hamerlik P, Rich JN.

JCI Insight. 2019 Apr 4;4(7). pii: 126140. doi: 10.1172/jci.insight.126140. eCollection 2019 Apr 4.

6.

Stem cell signature in glioblastoma: therapeutic development for a moving target.

Nakano I.

J Neurosurg. 2015 Feb;122(2):324-30. doi: 10.3171/2014.9.JNS132253. Epub 2014 Nov 14. Review.

PMID:
25397368
7.

Extracellular sphingosine-1-phosphate: a novel actor in human glioblastoma stem cell survival.

Riccitelli E, Giussani P, Di Vito C, Condomitti G, Tringali C, Caroli M, Galli R, Viani P, Riboni L.

PLoS One. 2013 Jun 24;8(6):e68229. doi: 10.1371/journal.pone.0068229. Print 2013.

8.

Elevated invasive potential of glioblastoma stem cells.

Cheng L, Wu Q, Guryanova OA, Huang Z, Huang Q, Rich JN, Bao S.

Biochem Biophys Res Commun. 2011 Mar 25;406(4):643-8. doi: 10.1016/j.bbrc.2011.02.123. Epub 2011 Mar 1.

9.

CD133+ glioblastoma stem-like cells induce vascular mimicry in vivo.

Chiao MT, Yang YC, Cheng WY, Shen CC, Ko JL.

Curr Neurovasc Res. 2011 Aug 1;8(3):210-9.

PMID:
21675958
10.

Targeting A20 decreases glioma stem cell survival and tumor growth.

Hjelmeland AB, Wu Q, Wickman S, Eyler C, Heddleston J, Shi Q, Lathia JD, Macswords J, Lee J, McLendon RE, Rich JN.

PLoS Biol. 2010 Feb 23;8(2):e1000319. doi: 10.1371/journal.pbio.1000319.

11.

Restriction of Replication of Oncolytic Herpes Simplex Virus with a Deletion of γ34.5 in Glioblastoma Stem-Like Cells.

Peters C, Paget M, Tshilenge KT, Saha D, Antoszczyk S, Baars A, Frost T, Martuza RL, Wakimoto H, Rabkin SD.

J Virol. 2018 Jul 17;92(15). pii: e00246-18. doi: 10.1128/JVI.00246-18. Print 2018 Aug 1.

12.

Glioblastoma stem cells: Molecular characteristics and therapeutic implications.

Bayin NS, Modrek AS, Placantonakis DG.

World J Stem Cells. 2014 Apr 26;6(2):230-8. doi: 10.4252/wjsc.v6.i2.230. Review.

13.

Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.

Iglesia RP, Prado MB, Cruz L, Martins VR, Santos TG, Lopes MH.

Stem Cell Res Ther. 2017 Apr 17;8(1):76. doi: 10.1186/s13287-017-0518-1.

14.

Genetic Evolution of Glioblastoma Stem-Like Cells From Primary to Recurrent Tumor.

Orzan F, De Bacco F, Crisafulli G, Pellegatta S, Mussolin B, Siravegna G, D'Ambrosio A, Comoglio PM, Finocchiaro G, Boccaccio C.

Stem Cells. 2017 Nov;35(11):2218-2228. doi: 10.1002/stem.2703. Epub 2017 Sep 29.

15.

Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting.

Huang Z, Cheng L, Guryanova OA, Wu Q, Bao S.

Protein Cell. 2010 Jul;1(7):638-55. doi: 10.1007/s13238-010-0078-y. Epub 2010 Jul 29. Review.

16.

Laminin alpha 2 enables glioblastoma stem cell growth.

Lathia JD, Li M, Hall PE, Gallagher J, Hale JS, Wu Q, Venere M, Levy E, Rani MR, Huang P, Bae E, Selfridge J, Cheng L, Guvenc H, McLendon RE, Nakano I, Sloan AE, Phillips HS, Lai A, Gladson CL, Bredel M, Bao S, Hjelmeland AB, Rich JN.

Ann Neurol. 2012 Nov;72(5):766-78. doi: 10.1002/ana.23674.

17.

Patient-derived glioblastoma stem cells respond differentially to targeted therapies.

Kanabur P, Guo S, Simonds GR, Kelly DF, Gourdie RG, Verbridge SS, Sheng Z.

Oncotarget. 2016 Dec 27;7(52):86406-86419. doi: 10.18632/oncotarget.13415.

18.

PNIPAAm-co-Jeffamine® (PNJ) scaffolds as in vitro models for niche enrichment of glioblastoma stem-like cells.

Heffernan JM, McNamara JB, Borwege S, Vernon BL, Sanai N, Mehta S, Sirianni RW.

Biomaterials. 2017 Oct;143:149-158. doi: 10.1016/j.biomaterials.2017.05.007. Epub 2017 May 6.

19.

G-quadruplex ligand RHPS4 radiosensitizes glioblastoma xenograft in vivo through a differential targeting of bulky differentiated- and stem-cancer cells.

Berardinelli F, Tanori M, Muoio D, Buccarelli M, di Masi A, Leone S, Ricci-Vitiani L, Pallini R, Mancuso M, Antoccia A.

J Exp Clin Cancer Res. 2019 Jul 16;38(1):311. doi: 10.1186/s13046-019-1293-x.

20.

Acidic pH with coordinated reduction of basic fibroblast growth factor maintains the glioblastoma stem cell-like phenotype in vitro.

Haley EM, Tilson SG, Triantafillu UL, Magrath JW, Kim Y.

J Biosci Bioeng. 2017 May;123(5):634-641. doi: 10.1016/j.jbiosc.2016.12.006. Epub 2017 Jan 4.

PMID:
28063758

Supplemental Content

Support Center